Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- CheckyesterdayChange DetectedThe page has removed a citation regarding an erratum for a study on the safety profile of upadacitinib in rheumatoid arthritis.SummaryDifference0.2%
- Check8 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.2) and the removal of a specific study citation related to Upadacitinib in rheumatoid arthritis treatment.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal related to a clinical study on upadacitinib for rheumatoid arthritis, including detailed study objectives, design, and inclusion/exclusion criteria. A new revision number has been added, indicating an update to the document.SummaryDifference8%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.